How many insider trades does FilingIQ track for TELA?

FilingIQ tracks 412 Form 4 insider transactions for TELA (TELA Bio, Inc.), covering filings from Nov 8, 2019 onwards. 23 of those were filed in the last 90 days.

Are TELA insiders net buyers or net sellers?

Across the full Form 4 history for TELA, 239 transactions (58%) were open-market purchases and 7 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TELA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TELA in?

TELA Bio, Inc. (TELA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $30.74M.

TELA insider trading

NasdaqGM Healthcare

TELA Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

412

Last 90 days

Buys / sells

58% / 2%

Market cap

$30.74M

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Company website: www.telabio.com

TELA insider activity at a glance

FilingIQ has scored 412 insider transactions for TELA since Nov 8, 2019. The most recent filing in our index is dated Feb 24, 2026.

Across the full history, 239 open-market purchases and 7 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TELA insider trades is 39.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TELA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TELA?: FilingIQ tracks 412 Form 4 insider transactions for TELA (TELA Bio, Inc.), covering filings from Nov 8, 2019 onwards. 23 of those were filed in the last 90 days.
Are TELA insiders net buyers or net sellers?: Across the full Form 4 history for TELA, 239 transactions (58%) were open-market purchases and 7 (2%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TELA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TELA in?: TELA Bio, Inc. (TELA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $30.74M.

Methodology & sources

Every TELA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.